Evidence map›Paper›PMID 29371584›Full record

ArticleThe American journal of case reports2018

Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung.

Mingxia Shi, Hongzhi Xu, Angela DiPoto Brahmbhatt, Eduardo Gonzalez-Toledo, Maria-Magdalena Georgescu

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingxia ShiDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Science Center, Shreveport, LA, USA.
Hongzhi XuDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Science Center, Shreveport, LA, USA.
Angela DiPoto BrahmbhattDivision of Anatomic Pathology, Children's National Medical Center, Washington, DC, USA.
Eduardo Gonzalez-ToledoDepartment of Radiology, Louisiana State University Health Science Center, Shreveport, LA, USA.
Maria-Magdalena GeorgescuDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Science Center, Shreveport, LA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Invasive mucinous adenocarcinoma (IMA) is a rare variant of adenocarcinoma of the lung. It frequently shows KRAS mutations, while ALK rearrangement is exceedingly rare. We present a case of ALK-rearranged IMA of the lung presenting with an unusual pattern of brain metastases, radiologically mimicking a cavernous angioma. CASE REPORT A 44-year-old non-smoker female was first diagnosed with lung right lower lobe IMA with ALK rearrangement. Five years after surgery followed by chemotherapy, she developed a sudden onset headache. Brain imaging revealed a hemorrhagic left frontal mass, suspicious for a cavernous angioma. However, the pathology of the resected lesion showed an ALK-rearranged brain metastasis from the IMA of the lung. Interestingly, the metastases showed perivascular tumor infiltrates, accompanied by focal mural invasion, vascular disruption, and hemorrhage. CONCLUSIONS To our knowledge, this is the first reported case of brain metastasis from an ALK-rearranged IMA of the lung. Further investigation of the clinical and pathological characteristics of the ALK-rearranged IMA, including awareness of the possibility for development of brain metastases with tumor-associated vasculopathy and hemorrhage, is warranted.

Indexed as

Gene RearrangementAdenocarcinoma, MucinousAdultAnaplastic Lymphoma KinaseBrain NeoplasmsDiagnosis, DifferentialFemaleHemangioma, Cavernous, Central Nervous SystemHumansLung NeoplasmsReceptor Protein-Tyrosine KinasesALK protein, humanAnaplastic Lymphoma KinaseReceptor Protein-Tyrosine Kinases

Identifiers

PMID29371584
PMCPMC5796364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.